A director at Cigna Group (The) sold/sold after exercising options 28,526 shares at 300.000USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Two Directors at Centene Corp bought 19,512 shares at between 0.000USD and 25.500USD. The significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
Approximately $3.0 billion of new debt securities rated New York , June 17, 2025 – Moody's Ratings (Moody's) has assigned an A2 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH) planned issuance of an estimated $3.0 billion of senior unsecured debt due in 20...
Six Directors at UnitedHealth Group bought 109,464 shares at between 0.000USD and 320.800USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Two Directors at Humana Inc bought 7,133 shares at between 0.000USD and 229.247USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Summary NexgenRx Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights NexgenRx Inc (NexgenRx) is a provider of health benefit claims adjudication and administration solutions. It adjudicates and pays drug, dental, and other extended healthcare claims on behalf of the health ...
New York , March 3, 2025 – Moody's Ratings (Moody's) has assigned a Baa2 senior unsecured debt rating to Humana Inc.'s (Humana, NYSE: HUM, senior debt at Baa2) planned issuance of up to $1.25 billion of senior unsecured notes due in 2035 and 2055. The net proceeds of this transaction are for general...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- (NYSE: HUM), a leading health and well-being company, today introduced a new value-based care agreement with to provide comprehensive cancer care support for eligible Humana Medicare Advantage members. Value-based care is a holistic, patient-centered model designed to improve patient health outcomes and quality of life while helping to make healthcare more affordable and accessible. This press release features multimedia. View the full release here: Cancer is the in the United States, with devastating physical, emotional, and financial consequences. Huma...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- The Humana Foundation, the philanthropic arm of (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern Kentucky. Following the flooding, some areas were also hit by winter snowstorm activity. Over the past week, torrential rains fell across Kentucky causing flooding in some areas while overflowing rivers onto neighborhoods and communities. At least 14 people died due to storm-related issues in Eastern Kentucky. Across the storm’s path, especially in areas like Pike and Madison...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare Advantage members in Alabama, Louisiana, Mississippi, Tennessee, and now Georgia with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) will have access to Monogram’s evidence-based nephrology and multispecialty value-based care in the comfort of their homes. This press release features multimedia. View the full release here: Value-based care focuses on ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.